Ligand validation:1FZK

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 1FZK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1FZK_NAG_A_500	2%	65%	0.391	0.679	0.48	0.85	-	1	0	0	100%	0.9333
2OL3_NAG_A_201	17%	61%	0.242	0.836	0.55	0.94	-	1	5	0	93%	0.9333
2FO4_NAG_A_900	16%	68%	0.282	0.853	0.56	0.67	-	-	0	0	100%	0.9333
1KJ2_NAG_E_401	14%	43%	0.293	0.849	1.14	1.08	1	2	0	1	100%	0.9333
1BQH_NAG_K_130	9%	11%	0.274	0.759	2.69	1.48	4	2	3	0	100%	0.9333
1KPU_NAG_A_500	5%	57%	0.319	0.723	0.79	0.87	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.